employ
polymeras
chain
reaction
pcr
techniqu
viru
detect
quantif
offer
advantag
high
sensit
reproduc
combin
extrem
broad
dynam
rang
number
qualit
quantit
pcr
viru
assay
describ
commerci
pcr
kit
avail
quantit
analysi
limit
number
clinic
import
virus
addit
permit
assess
viral
load
given
time
point
quantit
pcr
test
offer
possibl
determin
dynam
viru
prolifer
monitor
respons
treatment
virus
display
persist
defin
cell
type
distinct
latent
activ
infect
moreov
technic
point
view
employ
sequenti
quantit
pcr
assay
viru
monitor
help
identifi
fals
posit
result
caus
inadvert
contamin
sampl
trace
viral
nucleic
acid
pcr
product
review
provid
survey
current
stateoftheart
applic
realtim
pcr
technolog
viru
analysi
advantag
limit
rqpcr
methodolog
qualiti
control
issu
relat
standard
valid
diagnost
assay
discuss
polymeras
chain
reaction
pcr
power
tool
detect
minut
amount
nucleic
acid
due
exponenti
amplif
target
sequenc
exquisit
sensit
less
copi
transcript
readili
detect
even
high
background
unrel
nucleic
acid
establish
pcrbase
detect
method
provid
basi
rapid
reliabl
detect
viral
nucleic
acid
clinic
set
shown
monitor
viru
load
kinet
viru
prolifer
prognost
relev
cours
diseas
clinic
outcom
whalley
et
al
humar
et
al
snijder
et
al
biedermann
et
al
wagner
et
al
watzing
et
al
avail
quantit
viru
detect
test
therefor
paramount
import
clinic
manag
viru
infect
quantif
target
sequenc
realtim
quantit
pcr
rqpcr
base
continu
measur
accumul
reduct
fluoresc
signal
amplif
reaction
contrast
quantit
pcr
approach
base
data
analysi
end
pcr
endpoint
quantit
pcr
realtim
pcr
technolog
permit
detect
number
amplicon
gener
amplif
cycl
realtim
mode
kinet
quantit
pcr
techniqu
elimin
need
postamplif
handl
sampl
pave
way
toward
fulli
autom
detect
system
appropri
calibr
rqpcr
assay
use
standard
curv
permit
assess
absolut
copi
number
target
interest
result
typic
display
amplif
plot
result
seri
fluoresc
measur
taken
defin
time
point
amplif
process
one
import
featur
realtim
technolog
abil
monitor
increas
amount
product
earli
time
point
pcr
reaction
facilit
quantif
target
exponenti
phase
pcr
amplif
product
first
becom
detect
quantif
realtim
pcr
therefor
neither
affect
limit
concentr
reagent
variabl
cycl
condit
affect
quantif
endpoint
analysisbas
pcr
assay
optim
rqpcr
test
display
high
sensit
detect
limit
target
molecul
per
reaction
rqpcr
technolog
offer
broad
dynam
capac
facilit
quantif
across
sevenlog
rang
target
molecul
chen
et
al
jebbink
et
al
lindh
hannoun
owe
featur
rqpcr
becom
import
techniqu
detect
monitor
viru
infect
middeldorp
niester
niester
surveil
viral
load
use
indic
activ
infect
virushost
interact
respons
antivir
therapi
watzing
et
al
hausler
et
al
commerci
rqpcr
assay
avail
limit
number
viral
pathogen
includ
eg
human
immunodefici
viru
hiv
hepat
virus
b
c
hbv
hcv
cytomegaloviru
cmv
human
papilloma
viru
hpv
sarsassoci
coronaviru
sarscov
see
tabl
due
fact
quantit
monitor
viru
infect
becom
indispens
patient
diseas
manag
differ
clinic
set
homebrew
realtim
assay
establish
number
viral
target
implement
clinic
diagnosi
see
tabl
within
forese
futur
expect
diagnost
laboratori
continu
develop
inhous
method
quantif
mani
clinic
relev
viral
target
detect
quantif
without
targetspecif
probe
intercal
dye
dnabind
dye
like
ethidium
bromid
etbr
higuchi
et
al
yopro
ishiguro
et
al
sybr
green
fmc
bioproduct
rockland
usa
wittwer
et
al
zipper
et
al
bebo
bengtsson
et
al
intercal
nonspecif
manner
doublestrand
dna
molecul
bound
state
emit
fluoresc
excit
appropri
light
sourc
anneal
extens
step
increas
amount
dye
bind
newli
synthes
dna
strand
lead
maximum
fluoresc
emiss
end
elong
phase
soon
dna
denatur
pcr
cycl
intercal
dye
molecul
releas
solut
result
drop
fluoresc
fluoresc
record
cycl
end
elong
ryncarz
et
al
espi
et
al
kessler
et
al
oneil
et
al
stocher
et
al
whiley
et
al
ramaswami
et
al
ramaswami
et
al
schalasta
et
al
issa
et
al
eclips
stevenson
et
al
hepat
viru
hav
abravaya
et
al
komurianpradel
et
al
yang
et
al
princ
et
al
castelain
et
al
hu
et
al
mentel
et
al
van
elden
et
al
perkin
et
al
weidmann
et
al
ishizaki
et
al
oneil
et
al
stocher
et
al
hawrami
breuer
espi
et
al
loparev
et
al
tippl
et
al
campsal
et
al
lamp
primer
parida
et
al
phase
reflect
number
pcr
product
gener
amplif
process
morrison
et
al
import
consid
number
intercal
dye
molecul
thu
amount
fluoresc
signal
emit
greatli
influenc
length
pcr
amplicon
absolut
amount
initi
target
copi
determin
correct
factor
must
use
correctli
assess
number
target
molecul
piatak
et
al
compar
realtim
detect
format
system
base
use
intercal
dye
easier
establish
less
expens
targetspecif
fluorogen
probe
see
requir
moreov
signal
intens
quantif
result
affect
mutat
within
sequenc
encompass
primer
properti
may
advantag
pcr
analysi
virus
display
high
mutat
rate
eg
differ
rna
virus
sinc
point
mutat
target
sequenc
advers
effect
hybrid
effici
fluorogen
probe
detect
quantit
analysi
viral
target
sequenc
prone
mutat
may
compromis
detect
format
hand
lack
probe
assay
result
lower
sensit
specif
amplif
detect
specif
pcr
product
determin
sole
amplif
primer
dye
molecul
bind
nonspecif
pcr
product
primer
dimer
contribut
overal
fluoresc
signal
intens
may
therefor
lead
inaccur
quantif
target
transcript
artifact
may
also
result
gener
fluoresc
amplif
nac
templat
ntc
control
see
thu
affect
interpret
result
essenti
therefor
control
specif
amplifi
fragment
end
pcr
melt
curv
analysi
see
detect
format
base
specif
hybrid
one
two
fluorescencelabel
oligonucleotid
probe
target
sequenc
amplif
frequent
report
format
viru
detect
diagnost
assay
depend
chemistri
use
differ
type
fluorogen
probe
introduc
assay
describ
detect
viral
dna
rna
base
use
hydrolysi
probe
see
tabl
hydrolysi
probe
appli
biosystem
ab
foster
citi
ca
usa
also
refer
taqman
nucleas
probe
nonextend
targetspecif
oligonucleotid
probe
bind
target
strand
pcr
primer
dualli
label
fluoresc
report
dye
eg
fam
vic
coval
attach
end
quencher
dye
eg
tamra
coval
attach
end
report
molecul
taqman
probe
stimul
appropri
light
sourc
emit
fluoresc
energi
transfer
quencher
therebi
suppress
emiss
fluoresc
report
physic
principl
known
fluoresc
reson
energi
transfer
fret
selvin
transfer
energi
work
effici
across
short
distanc
decreas
rapidli
report
quencher
molecul
move
apart
pcr
dna
polymeras
extend
primer
hybrid
probe
cleav
exonucleas
activ
enzym
correspond
quencher
report
molecul
separ
energi
transfer
quencher
molecul
thu
abrog
report
start
emit
fluoresc
measur
end
extens
step
holland
et
al
well
establish
assay
linear
correl
number
releas
report
molecul
number
amplicon
synthes
pcr
cycl
correl
serv
basi
calcul
initi
copi
number
target
transcript
main
advantag
chemistri
includ
easi
probe
design
minor
restrict
appli
select
appropri
target
sequenc
fact
appar
main
reason
report
success
rate
new
rqpcr
assay
base
use
hydrolysi
probe
kubista
howev
short
amplicon
bp
requir
achiev
optim
amplif
effici
sinc
taqman
probe
molecul
cleav
cycl
melt
curv
analysi
amplicon
possibl
anoth
disadvantag
reduc
temperatur
strand
extens
requir
nucleas
activ
displac
cleav
probe
temperatur
suboptim
process
activ
taq
dna
polymeras
enzym
may
therefor
affect
amplif
effici
pcr
reaction
anoth
detect
format
frequent
use
detect
dna
virus
base
hybrid
probe
hybprob
caplin
et
al
method
reli
use
two
oligonucleotid
probe
hybrid
next
sequenc
locat
amplif
primer
one
probe
label
donor
dye
end
eg
fluorescein
emit
green
light
label
acceptor
dye
end
eg
lc
red
lc
red
emit
red
light
probe
design
hybrid
anneal
step
strand
headtotail
arrang
distanc
nucleotid
bring
two
dye
close
proxim
henc
name
kiss
probe
donor
dye
stimul
appropri
light
sourc
emit
fluoresc
probe
bound
specif
target
sequenc
fluoresc
energi
transfer
donor
acceptor
molecul
fret
excit
fluorophor
emit
fluoresc
signal
detect
measur
end
anneal
step
anneal
step
temperatur
cycler
rais
strand
extens
hybrid
probe
detach
target
solut
hybrid
probe
close
enough
permit
relev
energi
transfer
amount
red
fluoresc
emit
anneal
step
proport
number
pcr
product
gener
measur
fluoresc
kinet
pcr
permit
calcul
initi
target
copi
nitsch
et
al
advantag
method
hybrid
probe
hydrolyz
therebi
facilit
gener
ampliconspecif
melt
curv
see
potenti
disadvantag
requir
design
two
oligonucleotid
probe
capabl
hybrid
amplif
primer
depend
sequenc
target
region
may
difficult
find
appropri
space
place
two
primer
two
probe
close
proxim
viru
analysi
problem
may
aris
consensu
target
region
detect
multipl
strain
viru
need
identifi
less
commonli
use
detect
format
base
molecular
beacon
tyagi
kramer
molecular
beacon
oligonucleotid
probe
contain
flank
sequenc
nucleotid
design
complementari
interven
sequenc
complementari
target
interest
end
probe
label
fluoresc
nonfluoresc
quench
dye
dabcyl
respect
term
molecular
beacon
deriv
fact
solut
complementari
sequenc
probe
anneal
form
stemlik
structur
wherea
interven
sequenc
remain
singlestrand
loop
result
hairpin
structur
bring
fluoresc
dye
quencher
close
proxim
lead
effici
quench
fluorophor
energi
releas
quencher
dye
form
heat
collision
quench
presenc
specif
templat
interven
loop
sequenc
molecular
beacon
bind
target
lead
conform
transit
hairpin
structur
linear
structur
result
separ
fluorophor
quencher
energi
transfer
longer
occur
fluoresc
emit
detect
end
anneal
step
due
fluorogen
mechan
molecular
beacon
use
gener
melt
curv
final
extens
step
end
pcr
mean
control
specif
target
amplif
accord
earlier
report
well
design
molecular
beacon
capabl
discrimin
singl
basepair
mismatch
accur
probe
tyagi
et
al
reason
higher
specif
high
thermal
stabil
hairpin
structur
conform
favor
linear
structur
target
sequenc
perfectli
match
complementari
region
probe
probe
linear
hybrid
target
fluoresc
signal
gener
real
challeng
work
molecular
beacon
design
stem
loop
stabil
stem
high
hairpin
structur
retain
even
presenc
complementari
target
stabil
low
molecular
beacon
may
fold
altern
conform
place
fluorophor
vicin
quencher
lead
increas
background
signal
estim
melt
temperatur
stem
specif
softwar
zuker
dna
fold
program
avail
internet
url
http
wwwbioinforpiedu
use
pc
version
program
also
download
http
molecular
beacon
design
help
dedic
softwar
packag
term
beacon
design
avail
premier
biosoft
intern
url
wwwpremierbiosoftcom
approach
assess
specif
gener
pcr
product
applic
realtim
assay
base
use
intercal
dye
hybrid
probe
molecular
beacon
melt
curv
analysi
measur
fluoresc
perform
end
pcr
reaction
temperatur
reaction
tube
gradual
rais
complet
denatur
doublestrand
dna
molecul
occur
denatur
temperatur
temperatur
doubl
strand
dna
amplicon
denatur
targetprob
hybrid
melt
specif
melt
temperatur
melt
temperatur
temperatur
probetarget
hybrid
dissoci
accord
sequenc
length
gc
content
thu
lead
characterist
pattern
fluoresc
kinet
melt
curv
analysi
done
plot
intens
fluoresc
temperatur
gradient
logarithm
scale
melt
temperatur
profil
use
discrimin
full
length
amplicon
shorter
product
primer
dimer
reduc
moreov
nonspecif
pcr
product
display
differ
sequenc
differenti
specif
amplicon
even
singlebas
differ
identifi
differ
exploit
identifi
genotyp
highli
homolog
virus
appropri
valid
melt
curv
analysi
also
possibl
determin
quantiti
specif
amplicon
basi
calcul
initi
target
copi
number
payungporn
et
al
new
gener
modifi
rqpcr
probe
primer
reveal
increas
thermal
duplex
stabil
improv
specif
target
sequenc
recent
launch
differ
vendor
employ
modifi
oligonucleotid
primer
probe
provid
accur
target
discrimin
quantif
may
particularli
use
detect
quantit
analysi
tradit
problemat
target
sequenc
like
gcor
atrich
region
peptid
nucleic
acid
pna
nielsen
nucleic
acid
analog
phosphatesugar
backbon
replac
uncharg
polyamin
backbon
side
group
consist
nitrogen
purin
pyrimidin
base
ident
biolog
nucleic
acid
bind
complementari
base
sequenc
stronger
specif
achiev
dna
rna
probe
uhlmann
greater
stabil
reflect
higher
compar
correspond
dnadna
dnarna
duplex
pnadna
hybrid
significantli
affect
base
mismatch
dnadna
hybrid
singl
pnadna
mismatch
reduc
averag
compar
dnadna
duplex
allow
shorter
length
pna
probe
use
situat
longer
dna
probe
normal
employ
howev
specif
probe
requir
care
consider
pna
probe
roughli
melt
temperatur
standard
dna
probe
former
display
equal
high
specif
pna
probe
show
excel
chemic
biolog
stabil
complet
resist
nucleas
proteas
peptidas
commonli
use
degrad
dna
peptid
resist
enzymat
degrad
lifetim
pna
extend
vivo
vitro
pellestor
paulasova
consequ
applic
pna
chemistri
rqpcr
assay
pna
probe
design
hydrolysi
probe
moreov
pna
recogn
polymeras
thu
use
primer
rqpcr
assay
orum
et
al
practic
problem
pna
insolubl
water
oligom
greater
length
base
probe
base
length
tend
aggreg
problem
also
occur
purinerich
pna
probe
henc
best
perform
pna
probe
longer
nucleotid
display
balanc
nucleotid
composit
pna
backbon
exploit
develop
lightup
probe
wolff
et
al
svanvik
et
al
isacsson
et
al
principl
lightup
probe
base
presenc
singl
report
dye
becom
luminesc
upon
regular
hybrid
without
requir
conform
chang
contrast
detect
format
principl
permit
target
quantif
measur
increas
rather
fluctuat
fluoresc
intens
due
presenc
pna
backbon
probe
degrad
taq
dna
polymeras
extens
phase
comparison
oligonucleotidebas
probe
lightup
probe
reveal
faster
hybrid
stronger
bind
target
dna
effici
competit
reanneal
heatdenatur
templat
base
properti
lightup
probe
readili
implement
standard
realtim
pcr
protocol
taqman
minor
groov
bind
mgb
tm
probe
appli
biosystem
ab
foster
citi
ca
usa
short
oligonucleotid
character
conjug
minor
groov
binder
dihydrocyclopyrroloindol
less
commonli
end
kutyavin
et
al
chemic
modif
increas
hybrid
probe
facilit
highli
specif
bind
target
sequenc
minor
groov
dna
helix
differ
valu
complet
incomplet
match
probe
pronounc
thu
provid
basi
reliabl
discrimin
sequenc
display
minim
differ
base
pair
composit
moreov
probe
contain
quencher
dye
emit
fluoresc
within
detect
wavelength
rang
improv
elimin
spectral
overlap
fluoresc
emit
report
dye
result
greater
accuraci
measur
reporterspecif
signal
discrimin
viral
serotyp
strain
differ
even
singl
nucleotid
within
region
amplifi
two
differenti
label
taqman
mgb
probe
specif
one
viru
type
use
pcr
reaction
driven
singl
set
primer
geng
et
al
experi
use
two
mgb
probe
singl
rqpcr
reaction
abi
prism
instrument
reveal
excel
capabl
differenti
minim
mismatch
sequenc
unpublish
observ
howev
precis
quantif
two
target
hamper
spectral
interfer
crosstalk
report
dye
fluoresc
signal
fam
vic
detect
channel
term
lock
nucleic
acid
lna
describ
oligonucleotid
modif
character
presenc
one
bicycl
ribos
analog
braasch
corey
structur
resembl
nativ
nucleic
acid
lead
good
solubl
water
easi
handl
contrast
pna
mgb
chemistri
lna
modif
applic
primer
probe
rqpcr
assay
lna
substitut
dna
oligonucleotid
confer
except
biolog
stabil
significantli
increas
affin
complementari
dna
target
increas
thermal
stabil
depend
number
lna
monom
present
sequenc
lna
modif
greatli
increas
melt
temperatur
oligonucleotid
differ
perfectli
imperfectli
match
nucleic
acid
duplex
thu
facilit
discrimin
even
singl
base
mutat
owe
properti
lnacontain
oligonucleotid
use
rqpcr
assay
length
rang
nucleotid
nt
significantli
shorter
unmodifi
primer
probe
display
featur
provid
greater
flexibl
design
consensu
primer
probe
detect
partial
homolog
target
sequenc
relat
viral
speci
serotyp
final
experi
lnamodifi
oligonucleotid
rqpcr
assay
reveal
specif
sensit
superior
type
primer
probe
unpublish
observ
rel
high
cost
probe
impedi
implement
rqpcr
approach
possibl
use
detect
system
base
modifi
primer
gener
fluoresc
signal
upon
target
amplif
exampl
detect
system
includ
scorpion
primer
whitcomb
et
al
amplifour
primer
uehara
et
al
lux
tm
primer
invitrogen
carlsbad
ca
usa
nazarenko
et
al
qzyme
system
bd
anoth
recent
launch
primerbas
probeless
realtim
system
base
measur
gradual
reduct
fluoresc
signal
plexor
tm
promega
mannheim
frg
sherril
et
al
lead
invers
characterist
exponenti
amplif
curv
system
less
expens
probebas
detect
format
may
provid
attract
altern
especi
multipl
target
detect
simultan
multiplex
reaction
instanc
high
cost
synthesi
sever
specif
fluorigen
probe
avoid
howev
necessari
determin
probeless
detect
system
whether
sensit
specif
adequ
detect
format
chemistri
outlin
advantag
specif
limit
intercal
dye
significantli
cheaper
probe
bind
also
primer
dimer
spuriou
pcr
product
subsequ
melt
curv
analysi
increas
discrimin
power
dyebas
assay
add
complex
data
analysi
probeless
rqpcr
detect
system
also
lack
intrins
specif
control
offer
inclus
targetspecif
probe
therefor
less
commonli
use
clinic
diagnost
employ
specif
bind
fluorogen
probe
offer
greater
specif
target
detect
inclus
hybrid
step
pcr
reaction
also
increas
sensit
detect
compar
achiev
nest
pcr
southern
blot
hybrid
pcr
product
anoth
benefit
probebas
assay
intercal
dye
possibl
combin
two
even
probe
differ
label
one
pcr
reaction
multiplex
reaction
instanc
essenti
select
fluoresc
dye
minim
spectral
overlap
excit
emiss
order
avoid
phenomenon
crosstalk
import
howev
bear
mind
none
fluorescencebas
detect
system
elimin
nonspecif
amplif
emerg
misprim
primer
dimer
format
unless
fluorescencelabel
primer
use
nonspecif
product
remain
undetect
may
affect
amplif
effici
specif
target
final
quantif
result
recommend
therefor
optim
reaction
condit
initi
phase
assay
develop
employ
intercal
dye
subsequ
gel
electrophoresi
melt
curv
analysi
order
ensur
absenc
amplif
artefact
prior
implement
specif
probe
assay
hand
use
lnamodifi
hydrolysi
probe
particularli
success
establish
highli
specif
rqpcr
detect
assay
display
sensit
superior
system
moreov
sever
lnamodifi
probe
combin
multiplex
assay
without
relev
loss
sensit
realtim
pcr
technolog
permit
detect
quantif
viral
target
deriv
larg
varieti
differ
type
clinic
sampl
upon
isol
viral
dna
rna
differ
commerci
avail
nucleic
acid
extract
kit
viral
target
detect
primari
human
materi
includ
plasma
serum
peripher
blood
pb
bone
marrow
bm
mononuclear
cell
isol
pb
bm
saliva
buccal
nasopharyng
swab
sputum
tracheal
aspir
bronchoalveolar
lavag
cerebrospin
fluid
urin
stool
variou
solid
tissu
moreov
molecular
viru
detect
rqpcr
perform
tissu
cultur
paraffinembed
tissu
water
urban
sludg
plant
anim
viruscontain
specimen
kept
ambient
temperatur
store
sever
day
without
loss
yield
integr
virus
protect
nucleas
attack
long
protein
lipid
coat
disrupt
anderson
et
al
mani
year
guanidinium
thiocyan
method
describ
chomczynski
chomczynski
sacchi
among
sensit
reproduc
protocol
extract
viral
nucleic
acid
verhofsted
et
al
howev
procedur
timeconsum
laborintens
suscept
contamin
moreov
safeti
issu
associ
requir
use
phenolchloroformisoamylalcohol
extract
render
organ
extract
less
conveni
nucleic
acid
purif
method
clinic
applic
effort
elimin
use
hazard
solvent
extract
impur
order
save
time
labor
rapid
autom
nucleic
acid
extract
protocol
fewer
manipul
step
establish
commerci
major
readytous
sampl
prepar
kit
base
captur
dnarna
silica
matric
paramagnet
bead
coat
target
specif
ligand
elimin
organ
solvent
develop
appropri
technic
instrument
pave
way
implement
robot
workstat
autom
sampl
process
system
autom
sampl
prepar
includ
exampl
ampliprep
magna
pure
lc
system
roch
diagnost
workstat
like
biorobot
qiagen
see
tabl
despit
rel
high
cost
acquisit
mainten
requir
consum
instrument
recommend
implement
clinic
virolog
laboratori
obviou
advantag
larg
autom
system
viru
analysi
includ
increas
throughput
less
handson
time
staff
addit
improv
reproduc
higher
specif
lower
interlaboratori
variat
moreov
risk
prepcr
crosscontamin
significantli
reduc
mifflin
et
al
irrespect
extract
procedur
appli
manual
autom
chemistri
use
homebrew
approv
eg
analyt
specif
reagent
asr
ce
analyt
potenti
problem
affect
effici
reliabl
viral
nucleic
acid
purif
requir
consider
impur
contamin
present
nucleic
acid
isol
may
caus
fals
neg
result
pcr
analysi
owe
presenc
nucleas
enzym
inhibitor
adequ
control
puriti
nucleic
acid
prepar
perform
overtim
stabil
studi
use
well
defin
dna
rna
spike
ad
nucleic
acid
isol
step
detect
limit
viru
analysi
may
affect
restrict
sampl
volum
process
given
nucleic
acid
extract
protocol
number
commerci
avail
product
isol
nucleic
acid
suffer
limit
detect
low
viru
copi
number
virusenrich
roth
et
al
shyamala
et
al
highvolum
extract
method
hourfar
et
al
may
requir
revers
transcript
rt
step
highli
underestim
sourc
variabl
quantif
rna
virus
depend
complex
rna
target
choic
primer
enzym
reaction
condit
essenti
effici
fidel
rt
reaction
bustin
nolan
bustin
et
al
commonli
use
revers
transcriptas
includ
retrovir
enzym
amvrt
purifi
avian
myeloblastosi
virusinfect
chick
mmlvrt
product
pol
gene
moloney
murin
leukemia
viru
first
strand
cdna
synthesi
initi
nonspecif
primer
polyt
random
hexam
oligonucleotid
target
sequencespecif
primer
activ
rt
enzym
advers
affect
residu
blood
compon
heme
presenc
heparin
alcohol
phenol
high
salt
concentr
moreov
contamin
carri
rna
precipit
step
affect
measur
amount
rna
templat
lead
intertub
interexperiment
variabl
freeman
et
al
control
revers
transcript
step
address
see
section
owe
high
sensit
rapid
avail
test
result
use
pcr
rtpcr
becom
techniqu
choic
detect
mani
pathogen
dna
rna
virus
instanc
homebrew
detect
assay
must
employ
test
avail
commerci
kit
see
tabl
moreov
diagnost
approach
base
pcr
increasingli
use
monitor
respons
treatment
assess
progress
viral
infect
howev
outlin
occurr
fals
posit
result
attribut
inadvert
contamin
test
tube
amplif
product
previou
reaction
viral
nucleic
acid
present
high
level
differ
specimen
remain
impedi
diagnost
use
pcr
assay
potenti
drawback
use
realtim
pcr
comparison
convent
pcr
includ
inabl
monitor
amplicon
size
without
open
system
incompat
individu
platform
fluorogen
chemistri
moreov
initi
expens
realtim
pcr
may
prohibit
lowthroughput
laboratori
realtim
pcr
proven
cost
effect
implement
highthroughput
laboratori
martel
et
al
establish
realtim
technolog
offer
number
import
advantag
convent
pcr
includ
decreas
chanc
contamin
system
close
requir
handl
reaction
content
complet
pcr
addit
advantag
monitor
product
accumul
reaction
tube
elimin
requir
separ
detect
method
gel
electrophoresi
thu
shorten
effect
assay
time
consider
sinc
fluoresc
gener
amplif
reaction
proport
amount
pcr
product
semiquantit
estim
viru
copi
specimen
investig
feasibl
even
without
precis
calibr
assay
requir
truli
quantit
analysi
see
section
larg
number
realtim
pcr
assay
detect
viral
pathogen
includ
dna
rna
virus
describ
abe
et
al
kimura
et
al
ryncarz
et
al
kleiber
et
al
lallemand
et
al
monpoeho
et
al
tanaka
et
al
ohyashiki
et
al
furuta
et
al
watzing
et
al
latter
requir
special
care
specimen
process
suscept
rna
digest
ribonucleas
may
present
clinic
sampl
effici
revers
transcript
step
requir
prior
pcr
amplif
critic
sensit
rna
viru
detect
must
monitor
appropri
control
see
section
revers
transcript
realtim
pcr
appli
detect
numer
rna
virus
includ
exampl
human
immunodefici
viru
hiv
hepat
c
viru
hcv
human
tcell
lymphotrop
virus
enterovirus
ev
respiratori
syncyti
viru
rsv
influenza
virus
infa
infb
rotaviru
viral
pathogen
caus
gastroenter
pulmonari
infect
see
tabl
rtpcr
also
employ
detect
viral
messeng
rna
may
particularli
use
diagnosi
dna
virus
display
latent
phase
life
cycl
detect
viral
dna
case
may
permit
distinct
latent
product
infect
instanc
detect
mrna
express
product
infect
would
provid
evid
activ
viral
infect
apart
viral
mrna
analysi
presenc
absenc
activ
prolifer
viru
determin
serial
quantit
measur
rel
absolut
viral
load
see
section
addit
detect
individu
viral
pathogen
realtim
pcr
facilit
perform
multiplex
reaction
simultan
amplif
one
target
use
multipl
primer
probe
label
fluoresc
dye
display
differ
emiss
wavelength
possibl
combin
sever
primer
fluoresc
probe
realtim
assay
effici
mean
detect
multipl
virus
within
singl
reaction
recent
improv
design
probe
novel
combin
fluorophor
lightup
probe
system
see
section
improv
abil
discrimin
increas
number
target
discoveri
applic
nonfluoresc
quencher
render
wavelength
avail
previous
occupi
emiss
earli
quencher
improv
permit
inclus
greater
number
spectral
discern
oligoprob
per
reaction
highlight
need
singl
nonfluoresc
quencher
capabl
absorb
broad
rang
emiss
wavelength
recent
describ
multiplex
realtim
viru
detect
assay
includ
exampl
hepat
virus
b
c
hbv
hcv
human
immunodefici
viru
candotti
et
al
enter
virus
beuret
influenza
virus
infa
infb
parainfluenza
virus
respiratori
syncyti
viru
rsv
templeton
et
al
recent
introduc
multiplex
assay
permit
detect
speci
serotyp
human
adenovirus
see
section
ebner
et
al
futur
develop
novel
chemistri
combinatori
fluoresc
energi
transfer
tag
tong
et
al
improv
design
realtim
instrument
softwar
expect
broaden
applic
multiplex
realtim
pcr
assay
quantit
viru
analysi
realtim
pcr
measur
absolut
viru
load
individu
timepoint
monitor
prolifer
kinet
determin
amount
templat
realtim
pcr
perform
either
rel
absolut
quantif
absolut
quantif
determin
exact
number
nucleic
acid
target
present
sampl
relat
specif
unit
rel
quantif
describ
chang
amount
target
sequenc
compar
level
relat
sampl
freeman
et
al
commonli
rel
quantif
provid
suffici
inform
easier
establish
howev
monitor
cours
infect
absolut
quantif
use
order
express
result
unit
common
scientist
clinician
across
differ
platform
absolut
quantif
also
help
sequenti
specimen
avail
demonstr
chang
viru
level
viral
load
use
differenti
activ
latent
infect
moreov
measur
viral
load
realtimepcr
becom
wide
use
approach
studi
effect
antivir
therapi
emerg
drugresist
variant
clark
pa
et
al
well
known
exampl
includ
hepat
virus
c
b
hcv
hbv
human
immun
defici
viru
hiv
infect
clinic
manag
base
monitor
viral
load
peripher
blood
najioullah
et
al
garson
et
al
palmisano
et
al
import
quantit
viru
analysi
underscor
fact
differ
virus
may
persist
latent
state
primari
infect
healthi
immunocompet
individu
well
asymptomat
patient
caus
univers
posit
result
pcr
assay
mere
detect
viral
pathogen
pcr
may
relev
clinic
outcom
individu
contrast
consecut
assess
viru
load
seem
play
import
role
diagnosi
prognosi
patient
viral
reactiv
provid
basi
time
initi
appropri
treatment
yoshikawa
zhong
et
al
cesaro
et
al
clinic
import
exampl
virus
cytomegaloviru
cmv
member
human
herp
viru
famili
commonli
persist
peripher
blood
leukocyt
primari
infect
often
reactiv
sever
immunodefici
patient
common
caus
opportunist
infect
patient
aid
individu
receiv
either
solid
organ
allogen
stem
cell
transplant
view
fact
cmv
diseas
lifethreaten
patient
earli
diagnosi
reactiv
import
therapeut
manag
mere
detect
cmv
peripher
blood
pcr
distinguish
latent
activ
viru
infect
therefor
low
predict
valu
impend
diseas
measur
cmv
load
quantit
pcr
may
howev
provid
clinic
relev
inform
limay
et
al
detect
high
level
cmv
dna
document
increas
viral
load
serial
blood
specimen
report
herald
system
diseas
provid
basi
time
onset
preemptiv
antivir
therapi
ie
treatment
occurr
symptom
moreov
quantit
surveil
cmv
load
may
help
provid
measur
respons
therapi
rise
level
potenti
permit
earli
identif
antivir
drug
resist
robert
et
al
virus
threshold
level
defin
paramet
initi
antivir
therapi
determin
efficaci
requir
durat
treatment
van
esser
et
al
lipman
cotler
wagner
et
al
exampl
patient
undergo
organ
allogen
stem
cell
transplant
reactiv
epsteinbarr
viru
ebv
lead
syndrom
posttransplant
lymphoprolif
disord
ptld
risk
ptld
relat
defin
cutoff
valu
ebv
load
baiocchi
et
al
howev
monitor
ebv
peripher
blood
mononuclear
cell
andor
plasma
detect
rise
viral
load
permit
earli
recognit
impend
ptld
thu
provid
basi
time
initi
antivir
treatment
clinic
manag
syndrom
orii
et
al
wagner
et
al
less
well
known
exampl
virus
measur
viral
load
quantit
pcr
appear
clinic
import
includ
human
polyoma
viru
bk
bkv
human
papilloma
viru
quantif
bkv
load
serum
appear
facilit
diagnosi
bk
virusassoci
nephropathi
renal
transplant
recipi
limay
et
al
amount
dna
cervic
smear
report
use
predictor
progress
carcinoma
situ
josefsson
et
al
howev
assess
absolut
viral
load
given
time
point
necessarili
reflect
risk
viral
diseas
instanc
recent
studi
pediatr
patient
allogen
stem
cell
transplant
investig
potenti
serial
realtim
pcr
analysi
facilit
diagnosi
invas
adenoviru
adv
infect
earli
preclin
stage
patient
ultim
develop
fatal
dissemin
diseas
high
level
adv
copi
peripher
blood
ml
other
display
rel
low
peak
level
rang
copiesml
regardless
maximum
adv
level
reach
quantit
monitor
viru
load
realtim
pcr
usual
reveal
rise
viru
copi
number
sever
week
onset
clinic
symptom
indic
detect
viru
prolifer
kinet
better
predict
valu
instanc
clinic
relev
evalu
dynam
chang
determin
serial
rqpcr
analys
shown
previous
differ
quantit
pcr
assay
tenfold
increas
respect
target
copi
number
well
beyond
intrins
variabl
method
provid
reliabl
evid
expand
process
lion
et
al
detect
rise
viral
load
serial
realtim
pcr
analysi
demonstr
presenc
activ
infect
also
elimin
technic
problem
inher
pcr
diagnosi
occurr
fals
posit
pcr
test
due
inadvert
contamin
extran
nucleic
acid
limit
homolog
among
differ
strain
serotyp
even
speci
belong
viral
genu
major
challeng
establish
realtim
pcr
assay
detect
entir
spectrum
virus
potenti
clinic
relev
human
adenovirus
adv
divid
six
speci
af
serotyp
individu
serotyp
may
contain
number
differ
strain
import
exampl
differ
approach
describ
detect
quantifi
human
adenovirus
adv
speciesspecif
realtim
pcr
assay
requir
six
separ
reaction
contain
individu
primer
probe
system
permit
quantit
analysi
serotyp
within
speci
provid
clinic
use
rel
labori
approach
recent
report
econom
panadenoviru
detect
assay
multiplex
pcr
combin
differ
primerprob
system
two
reaction
describ
ebner
et
al
detect
human
adenovirus
one
rqpcr
reaction
use
singl
consensu
primerprob
system
feasibl
heim
et
al
requir
lower
stringenc
condit
target
amplif
thu
potenti
compromis
specif
assay
clinic
import
exampl
virus
requir
quantit
analysi
differ
genotyp
mutat
variant
includ
bloodborn
virus
hiv
hcv
hbv
hiv
infect
patient
genotyp
assay
avail
facilit
identif
mutat
viral
genom
associ
resist
particular
drug
clark
pa
et
al
type
analysi
permit
select
appropri
antiretrovir
regimen
provid
indic
timepoint
treatment
need
chang
patient
suffer
hcv
infect
inform
presenc
specif
genotyp
use
addit
viral
load
see
determin
durat
antivir
therapi
easl
similarli
success
antivir
treatment
hbv
infect
patient
seem
correl
genotyp
detect
sugauchi
et
al
common
procedur
viru
genotyp
target
amplif
use
consensu
primermedi
pcr
follow
sequenc
amplifi
fragment
germer
et
al
chow
et
al
vernon
et
al
plantier
et
al
presenc
mix
viru
popul
approach
seriou
limit
owe
preferenti
amplif
domin
viru
strain
prevent
identif
subdomin
strain
sequenc
account
less
entir
viral
load
known
viru
variant
directli
target
quantifi
specif
design
rqpcr
assay
exploit
particularli
high
discrimin
capac
primer
probe
carri
one
modif
describ
identifi
particular
viru
variant
interest
subsequ
quantit
analysi
pcrbase
algorithm
may
employ
exemplifi
fig
select
quantif
human
adv
serotyp
approach
permit
highli
sensit
specif
quantif
even
presenc
multipl
adv
serotyp
differ
speci
reliabl
quantif
viral
pathogen
clinic
specimen
realtim
pcr
requir
normal
defin
standard
implement
variou
control
indic
number
virus
detect
clinic
specimen
depend
type
materi
investig
liquid
specimen
serum
plasma
cerebrospin
fluid
viral
load
usual
indic
per
volum
unit
eg
millilit
sampl
extracellular
virus
solid
specimen
stool
commonli
report
per
mass
unit
eg
gram
number
intracellular
virus
specimen
peripher
blood
leukocyt
buccal
swab
biopsi
materi
gener
indic
per
number
cell
eg
tissu
investig
cell
number
clinic
specimen
easili
assess
coamplif
singlecopi
housekeep
gene
extracellular
viru
detect
size
clinic
sampl
use
viru
isol
need
measur
permit
accur
assess
viral
load
abil
detect
serotyp
without
specif
posit
specif
pcr
assay
speci
f
quantif
viral
target
control
gene
gener
perform
extern
standard
watzing
et
al
standard
curv
use
refer
quantit
analysi
establish
titrat
precis
defin
ident
amplifi
templat
relat
sampl
matrix
well
establish
realtim
pcr
assay
provid
remark
reproduc
result
low
intraand
interassay
variabl
intern
control
essenti
prerequisit
quantit
target
analysi
competit
pcr
format
niester
therefor
common
featur
realtim
pcr
platform
howev
despit
high
reproduc
realtim
pcr
assay
amplif
replic
sampl
regard
instrument
reliabl
quantif
convent
pcr
assay
fals
posit
result
commonli
caus
contamin
pcr
reaction
amplif
product
previou
test
carryov
homolog
genom
dna
altern
fals
posit
result
may
aris
nonspecif
bind
primer
irrelev
sequenc
latter
problem
greatli
reduc
realtim
pcr
assay
implement
specif
hybrid
probe
lead
gener
fluoresc
signal
upon
bind
amplifi
product
although
realtim
pcr
assay
perform
fluorescencebas
instrument
absenc
postamplif
handl
greatli
reduc
risk
contamin
pcr
product
import
bear
mind
problem
entir
elimin
contamin
may
occur
leakag
tube
microtit
plate
lid
tightli
close
breakag
glass
capillari
lead
spillag
amplif
mixtur
nucleotid
dttp
substitut
dutp
pcr
reaction
amplicon
differ
genom
dna
presenc
dutp
instanc
problem
contamin
pcr
product
easili
reduc
implement
digest
step
uracildnaglycosylas
ung
prior
amplif
reaction
use
pretreat
pcr
reaction
digest
newli
synthes
pcr
product
prevent
heatmedi
inactiv
enzym
start
amplif
although
routin
use
ung
highli
effect
complet
erad
problem
contamin
viru
analysi
import
sourc
carryov
contamin
patient
materi
contain
high
titer
viral
pathogen
affect
enzymat
digest
use
ung
risk
contamin
extran
viral
nucleic
acid
reduc
extrem
care
handl
clinic
sampl
skill
personnel
strict
separ
work
area
well
establish
precaut
recommend
pcr
work
kwok
higuchi
sarkar
sommer
scherczing
et
al
bustin
moreov
multipl
neg
control
ie
reaction
lack
templat
socal
notempl
control
ntc
reaction
includ
nonhomolog
templat
noamplif
control
nac
must
includ
assay
permit
identif
contamin
prevent
fals
interpret
posit
result
view
great
sensit
pcr
occurr
fals
neg
result
highli
underestim
problem
absenc
posit
signal
sampl
contain
viral
target
may
result
inhibitori
substanc
present
clinic
specimen
analyz
low
effici
failur
viral
nucleic
acid
extract
inadequ
pcr
amplif
case
rna
viru
analysi
ineffici
revers
transcript
effici
nucleic
acid
isol
revers
transcript
amplif
assess
ad
defin
standard
sampl
step
artifici
construct
gener
clone
specif
viral
target
sequenc
plasmid
often
use
extern
control
amplif
step
howev
handl
plasmid
harbor
target
nucleic
acid
sequenc
danger
sourc
contamin
order
avoid
risk
crosscontamin
includ
well
defin
intern
control
physic
properti
similar
target
interest
recommend
spike
specimen
nonhuman
natur
occur
virus
see
altern
socal
armor
rna
technolog
implement
intern
control
sampl
investig
spike
known
concentr
synthet
rna
standard
protect
degrad
packag
pseudovir
particl
paslosk
et
al
laboratori
use
phocin
seal
herp
viru
type
phhv
dna
viru
control
phocin
distemp
viru
pdv
rna
viru
control
kindli
provid
us
niester
depart
virolog
univers
hospit
rotterdam
netherland
clinic
specimen
test
presenc
quantiti
dna
virus
spike
defin
amount
phhv
prior
process
presenc
absenc
expect
level
fluoresc
signal
obtain
upon
realtim
amplif
control
viru
permit
assess
effici
nucleic
acid
isol
possibl
effect
inhibitori
agent
amplif
step
similarli
clinic
specimen
investig
realtim
pcr
rna
virus
spike
defin
quantiti
pdv
niester
watzing
et
al
rna
extract
revers
transcript
amount
control
viru
determin
realtim
pcr
analysi
presenc
expect
result
indic
adequ
extract
revers
transcript
viral
rna
lack
inhibitori
effect
amplif
result
quantit
viru
analysi
clinic
specimen
deem
elig
evalu
quantit
analysi
respect
control
viru
reveal
readout
expect
rang
rapidli
grow
number
public
quantif
viral
target
demonstr
increas
import
quantit
viru
detect
differ
area
research
clinic
diagnosi
detect
viral
load
dynam
prolifer
infecti
pathogen
prognost
relev
number
clinic
situat
serv
basi
guid
therapeut
intervent
orum
et
al
whitcomb
et
al
uehara
et
al
varieti
predominantli
homebrew
method
use
quantif
viral
target
lack
comprehens
inform
qualiti
control
measur
publish
report
render
comparison
data
gener
differ
diagnost
laboratori
rather
difficult
desir
therefor
establish
standard
technic
approach
quantit
viru
analysi
autom
entir
process
isol
viral
nucleic
acid
quantif
would
provid
conveni
way
elimin
interlaboratori
variat
necessari
prerequisit
gener
diagnost
rqpcr
result
compar
laboratori
includ
use
qualiti
control
reagent
calibr
standard
particip
multicent
qualiti
control
program
due
lack
standard
refer
materi
absenc
intern
accredit
bodi
differ
program
qualiti
control
clinic
virolog
qualiti
control
molecular
diagnost
qcmd
url
http
wwwqcmdorg
establish
activ
support
european
commiss
endors
european
societi
clinic
virolog
escv
european
societi
clinic
microbiolog
infecti
diseas
escmid
qcmd
independ
nonprofit
organ
design
develop
provid
qc
materi
profici
program
increas
number
viral
target
howev
number
current
avail
intern
accept
control
standard
qc
reagent
limit
restrict
mainli
bloodborn
virus
hbv
hcv
certif
accredit
diagnost
laboratori
becom
increasingli
import
order
document
expertis
qualiti
work
wide
accept
criteria
qualiti
assur
certif
clinic
laboratori
includ
iso
standard
accord
guidelin
necessari
appli
method
calibr
measur
system
particip
interlaboratori
comparison
program
altern
mechan
assur
qualiti
analyt
procedur
exampl
collabor
effort
europ
support
european
commiss
includ
concert
action
focus
standard
clinic
implement
differ
diagnost
approach
kind
intern
collabor
may
serv
good
exampl
futur
effort
aim
develop
wide
applic
concept
quantit
viru
diagnost
base
realtim
pcr
technolog
